EBCC-6 Press releases

16 April 2008

• Hereditary breast cancer – a high cost to patient and healthcare provider alike
• Obese women disadvantaged in both breast cancer treatment and diagnosis
• MRI before surgery leads to better-adapted treatment for breast cancer
• Pregnant patients lose out in breast cancer treatment; a new approach is needed

17 April 2008

• New research shows no link between aromatase inhibitors and cardiovascular problems
• New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients
• New type of drug shrinks primary breast cancer tumours significantly in just six weeks; research provides leads to a new target in cancer treatment – the cancer stem cell
• First study on the efficacy of standard chemotherapy in women with metastatic BRCA1/2 breast cancer shows it works better than against sporadic tumours

18 April 2008

• Two studies find mammograms benefit women up to the age of 75, and that three-yearly screening intervals are best
• Acupuncture relieves hot flushes in breast cancer patients taking tamoxifen
• Combining trastuzumab with neoadjuvant chemotherapy before surgery improves response rates without major adverse effects in women with HER2 positive tumours
• Countries could save millions of Euros a year if follow-ups for breast cancer patients were led by specialist nurses rather than physicians
• Breast cancers behave differently before and after the age of 70: could immune defence mechanisms play a role?

EBCC-6 Press conferences

View EBCC-6 Press conferences

TV spot

See an interview from FAB (Berlin TV) with Dr. Sibylle Loibl concerning her resesearch on pregnant cancer patients (in German). Click here.